CD99 Drives Terminal Differentiation of Osteosarcoma Cells by Acting as a Spatial Regulator of ERK 1/2-Reference-Cited by-同舟云学术

CD99 Drives Terminal Differentiation of Osteosarcoma Cells by Acting as a Spatial Regulator of ERK 1/2

Published:2014-04-22 Issue:5 Volume:29 Page:1295-1309
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Sciandra Marika¹,Marino Maria Teresa²,Manara Maria Cristina¹²,Guerzoni Clara²,Grano Maria³,Oranger Angela³,Lucarelli Enrico⁴,Lollini Pier‐Luigi⁵,Dozza Barbara⁴,Pratelli Loredana⁶,Di Renzo Maria Flavia⁷,Colombo Mario Paolo⁸,Picci Piero¹²,Scotlandi Katia¹²

Affiliation:

1. CRS Development of Biomolecular Therapies, Laboratory of Experimental OncologyRizzoli Orthopedic InstituteBolognaItaly

2. PROMETEO Laboratory, STB, RIT DepartmentRizzoli Orthopedic InstituteBolognaItaly

3. Department of Basic Medical SciencesNeuroscience and Sense Organs, Section of Human Anatomy and HistologyBariItaly

4. Laboratory of Orthopedic Pathology and Osteoarticular Tissue RegenerationRizzoli Orthopedic InstituteBolognaItaly

5. Department of Experimental, Diagnostic, and Specialty MedicineUniversity of BolognaBolognaItaly

6. Clinical PathologyRizzoli Orthopedic InstituteBolognaItaly

7. Department of Oncological SciencesInstitute for Cancer Research and TreatmentCandioloTorinoItaly

8. Molecular Immunology Unit, Department of Experimental Oncology and Molecular MedicineFondazione IRCCS “Istituto Nazionale dei Tumori”MilanoItaly

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.2141

Reference55 articles.

1. New targets and approaches in osteosarcoma

2. The Genetics of Osteosarcoma

3. Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma

4. Neoadjuvant Chemotherapy With High-Dose Ifosfamide, High-Dose Methotrexate, Cisplatin, and Doxorubicin for Patients With Localized Osteosarcoma of the Extremity: A Joint Study by the Italian and Scandinavian Sarcoma Groups

5. Bone and soft tissue sarcomas are often curable-But at what cost?

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles;International Journal of Molecular Sciences;2024-01-27

2. Mesenchymal progenitor cells from non-inflamed versus inflamed synovium post-ACL injury present with distinct phenotypes and cartilage regeneration capacity;Stem Cell Research & Therapy;2023-06-25

3. Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability;European Journal of Medicinal Chemistry;2023-05

4. Application of shear stress for enhanced osteogenic differentiation of mouse induced pluripotent stem cells;Scientific Reports;2022-11-08

5. Comprehensive analysis of potential cellular communication networks in advanced osteosarcoma using single-cell RNA sequencing data;Frontiers in Genetics;2022-10-11